Circadian timing of first-line chemoimmunotherapy is associated with survival in extensive-stage small cell lung cancer.

Yucel MH, Mildanoglu MM, Engin Delipoyraz E, Ozcelik H, Sunger E, Fidan S, Terzioglu C, Cakir T, Muglu H, Cakan Demirel B, Hamdard J, Kutlu Y, Acıkgoz O, Seker M, Bilici A

Open source

DOI: 10.1080/2162402x.2026.2738262
Published: 2026 Dec 31
Container: Oncoimmunology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/2162402x.2026.2738262,
  title = {Circadian timing of first-line chemoimmunotherapy is associated with survival in extensive-stage small cell lung cancer.},
  author = {Yucel MH and Mildanoglu MM and Engin Delipoyraz E and Ozcelik H and Sunger E and Fidan S and Terzioglu C and Cakir T and Muglu H and Cakan Demirel B and Hamdard J and Kutlu Y and Acıkgoz O and Seker M and Bilici A},
  year = {2026},
  journal = {Oncoimmunology},
  doi = {10.1080/2162402x.2026.2738262},
  url = {https://doi.org/10.1080/2162402x.2026.2738262}
}

RIS

TY  - JOUR
TI  - Circadian timing of first-line chemoimmunotherapy is associated with survival in extensive-stage small cell lung cancer.
AU  - Yucel MH
AU  - Mildanoglu MM
AU  - Engin Delipoyraz E
AU  - Ozcelik H
AU  - Sunger E
AU  - Fidan S
AU  - Terzioglu C
AU  - Cakir T
AU  - Muglu H
AU  - Cakan Demirel B
AU  - Hamdard J
AU  - Kutlu Y
AU  - Acıkgoz O
AU  - Seker M
AU  - Bilici A
PY  - 2026
JO  - Oncoimmunology
DO  - 10.1080/2162402x.2026.2738262
UR  - https://doi.org/10.1080/2162402x.2026.2738262
ER  -

APA

MH, Y., MM, M., E, E. D., H, O., E, S., S, F., C, T., T, C., H, M., B, C. D., J, H., Y, K., O, A., M, S., & A, B. (2026). Circadian timing of first-line chemoimmunotherapy is associated with survival in extensive-stage small cell lung cancer.. Oncoimmunology. https://doi.org/10.1080/2162402x.2026.2738262

Source records

pubmed · retrieved 2026-09-26T04:47:36.384Z